Tag: Real Goods Solar Inc

  • Major Micro-cap Bearish Stocks: Voxeljet (NYSE:VJET), Rexahn Pharmaceuticals (NYSE:RNN), Idera Pharmaceuticals (NASDAQ:IDRA) and Real Goods Solar (NASDAQ:RGSE)

    Voxeljet AG (ADR)(NYSE:VJET) tumbled to a record low after the company said it’s pricing its public offering of three million American Depositary Shares (ADSs) at $15.00 each – a 19% discount to Thursday’s closing price of $18.55. Voxeljet AG (ADR) (NYSE:VJET) shares after opening at $15.93 on last trade day and at the end of the day closed at $15.10. Company price to sales ratio in past twelve months was calculated as 21.39 and price to cash ratio as 500.41. Voxeljet AG (ADR) (NYSE:VJET) showed a negative weekly performance of -39.70%.

    Brinson Patrick initiated coverage on shares of Rexahn Pharmaceuticals (NYSE:RNN) in a research note released on Monday morning, TheFlyOnTheWall.com reports. The firm issued an outperform rating on the stock. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) shares fell -6.03% in last trading session and ended the day on $1.09. RNN return on equity ratio is recorded as -81.70% and its return on assets is -49.00%. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN)yearly performance is 263.33%.

    TheStreet Quant Ratings rates Idera Pharmaceuticals Inc (NASDAQ:IDRA) as a sell. The company’s weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and weak operating cash flow. Idera Pharmaceuticals Inc (NASDAQ:IDRA) shares moved down -9.14% in last trading session and was closed at $3.28, while trading in range of $3.24 – 3.77. Idera Pharmaceuticals Inc (NASDAQ:IDRA) year to date (YTD) performance is -29.16%.

    Real Goods Solar, Inc. (NASDAQ:RGSE) and SEC SUSD Solar One, LLC, have executed agreements to begin construction on solar energy projects at up to 22 sites within the Stockton Unified School District (SUSD). Real Goods Solar, Inc. (NASDAQ:RGSE) weekly performance is -18.87%. On last trading day company shares ended up $3.31. Real Goods Solar, Inc. (NASDAQ:RGSE) distance from 50-day simple moving average (SMA50) is -18.25%. Analysts mean target price for the company is $5.75.